YayaNews LogoYaya Financial News
美股Neutral$ATAI $LLY

Psychedelic drugmaker AtaiBeckley shares soar 66% on Eli Lilly buyout talks (LLY:NYSE)

Eli Lilly may acquire AtaiBeckley, signaling Big Pharma’s rising interest in psychedelic mental health drugs.

Financial news writerUpdated: 0 ViewsSource Seeking Alpha

YayaNews contributes financial news and market context through the YayaNews editorial workflow.

Psychedelic drugmaker AtaiBeckley shares soar 66% on Eli Lilly buyout talks (LLY:NYSE)
Image Source: Seeking Alpha

Eli Lilly may acquire AtaiBeckley, signaling Big Pharma’s rising interest in psychedelic mental health drugs.

Psychedelic drugmaker AtaiBeckley shares soar 66% on Eli Lilly buyout talks (LLY:NYSE) | Seeking Alpha

Save

Play

(

1min

)

Comments

Ivan Kovbasniuk/iStock via Getty Images

Eli Lilly & Co.

(

LLY

)

is in talks to acquire

AtaiBeckley (

ATAI

), underscoring growing interest from large drugmakers in the once-fringe area of psychedelic medicine, according to

Bloomberg News.

The pharmaceuticals group could announce a takeover of the New York-based drugmaker

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please

report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search field

Entering text into the input field will update the search result below

Entering text into the input field will update the search result below

Recommended For You

More

Trending News

See More

»

Disclaimer

Original YayaNews editorial coverage, published for informational purposes.

This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.

Share

Topics & Symbols

Topics & symbols

Continue Reading

Previous & next

Related Reading

Go to Channel